Vaccine was stored in fridge on 25-jan-2023 and administered to the patient on 27-Feb-2023.; No adverse event; A Moderna bivalent vaccine was given to a patients two days after the beyond use date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (A Moderna bivalent vaccine was given to a patients two days after the beyond use date), PRODUCT STORAGE ERROR (Vaccine was stored in fridge on 25-jan-2023 and administered to the patient on 27-Feb-2023.) and NO ADVERSE EVENT (No adverse event) in a 62-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7170B) for COVID-19 prophylaxis.     Previously administered products included for COVID-19 prophylaxis: Moderna COVID-19 Vaccine (Dose 1, Batch number: 010M20A.) on 29-Jan-2021, Moderna COVID-19 Vaccine (Dose 2, Batch number: 012A21A.) on 27-Feb-2021, Moderna COVID-19 Vaccine (Dose 3 and Batch number: 004S21A.) on 19-Nov-2021; for Product used for unknown indication: Prevnar 13. Past adverse reactions to the above products included No adverse event with Moderna COVID-19 Vaccine, Moderna COVID-19 Vaccine, Moderna COVID-19 Vaccine and Prevnar 13. Concurrent medical conditions included Contrast media allergy (Allergic to contrast dye.) and Drug allergy (Allergic to Amlodipine.).    On 27-Feb-2023, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .5 milliliter. On 27-Feb-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (A Moderna bivalent vaccine was given to a patients two days after the beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored in fridge on 25-jan-2023 and administered to the patient on 27-Feb-2023.) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (A Moderna bivalent vaccine was given to a patients two days after the beyond use date), PRODUCT STORAGE ERROR (Vaccine was stored in fridge on 25-jan-2023 and administered to the patient on 27-Feb-2023.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (A Moderna bivalent vaccine was given to a patients two days after the beyond use date) and PRODUCT STORAGE ERROR (Vaccine was stored in fridge on 25-jan-2023 and administered to the patient on 27-Feb-2023.).    No concomitant medications were provided.  It was reported that the vaccine was stored in fridge on 25-jan-2023 and administered to the patient on 27-Feb-2023.   No treatment medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 27-Feb-2023: Significant Follow Up received on 27-FEB-2023: Reporters details added, patient demographics added, Concurrent Conditions added, Historical vaccine added, Suspect vaccine administration date added, Dose information updated, Batch number added, event onset date added, event product storage error added, and narrative updated.